共 44 条
[1]
Logan CV(2015)Congenital Myasthenic syndrome type 19 is caused by mutations in COL13A1, encoding the atypical non-fibrillar collagen type XIII α1 Chain Am J Hum Genet. 97 878-85
[2]
Cossins J(2019)The 2020 version of the gene table of neuromuscular disorders (nuclear genome) Neuromuscul Disord 29 980-1018
[3]
Rodríguez-Cruz PM(1990)The alpha 1 chain of type XIII collagen consists of three collagenous and four noncollagenous domains, and its primary transcript undergoes complex alternative splicing J Biol Chem 265 16922-16928
[4]
Parry DA(2002)The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin J Biol Chem. 277 23092-9
[5]
Maxwell S(2017)Collagen XIII secures pre- and postsynaptic integrity of the neuromuscular synapse Hum Mol Genet. 26 2076-2090
[6]
Martínez-Martínez P(2010)Muscle-derived collagen XIII regulates maturation of the skeletal neuromuscular junction J Neurosci. 30 12230-41
[7]
Benarroch L(2019)Congenital myasthenic syndrome caused by novel COL13A1 mutations J Neurol. 266 1107-1112
[8]
Bonne G(2019)Congenital myasthenic syndrome type 19 due to a novel mutation in the COL13A1 GENE Muscle Nerve 60 33-34
[9]
Rivier F(2019)The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations Brain. 142 1547-1560
[10]
Hamroun D(undefined)undefined undefined undefined undefined-undefined